☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
77-0207692
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
PLT
|
New York Stock Exchange
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☐
|
|
|
Emerging growth company
|
☐
|
PART I. FINANCIAL INFORMATION
|
Page No.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
Regarding the Polycom acquisition: (i) we may be unable to integrate Polycom's business within our own in a timely and cost-efficient manner or do so without adversely impacting operations, including new product launches; (ii) expected synergies or operating efficiencies may fail to materialize in whole or part or may not occur within expected time-frames; (iii) the acquisition and our subsequent integration efforts may adversely impact relationships with customers, suppliers and strategic partners and their operating results and businesses generally (including the diversion of management time on transaction-related issues); (iv) we may be unable to retain and hire key personnel; (v) our increased leverage as a result of the transaction is substantially greater than prior to the acquisition which may pose risks, including reduced flexibility in how we use our cash and to make changes in our operations in response to business or economic conditions, increased borrowing costs, as well as penalties or costs should we fail to comply with terms of the financial agreements such as debt ratios and financial and operation performance targets; (vi) negative effects on the market price of our common stock as a result of the transaction, particularly in light of the issuance of our stock in the transaction; (vii) our financial reporting including those resulting from the adoption of new accounting pronouncements and associated system implementations in the context of the transaction, our ability to forecast financial results of the combined company and that we may be unable to successfully integrate our reporting system causing an adverse impact to our ability to make timely and accurate filings with the SEC and other domestic and foreign governmental agencies; (viii) the potential impact of the transaction on our future tax rate and payments based on our global entity consolidation efforts and our ability to quickly and cost effectively integrate foreign operations; (ix) the challenges of integrating the supply chains of the two companies; (x) the challenges of sales execution across different product lines; (xi) our expectations regarding the potential that our due diligence did not uncover risks and potential liabilities of Polycom;
|
•
|
the nature and extent of competition we face, particularly subsequent to the acquisition of Polycom as it relates to our ability to adapt to new competitors and changing markets;
|
•
|
the impact of product transitions underway which are replacing or upgrading nearly every major product in our product portfolio;
|
•
|
the impact of customer brand preferences on Consumer and Enterprise market demands;
|
•
|
the impact of our adoption of a new corporate branding identity, including any confusion or harm to our reputation resulting therefrom;
|
•
|
the impact of ongoing integration, restructuring and disaggregation activities on our operations, including on employees, distributors, VAR's, suppliers and customers from the Polycom acquisition;
|
•
|
our ability to realize and achieve positive financial results projected to arise in the our key markets from UC&C adoption could be adversely affected by a variety of factors including the following: (i) as UC&C becomes more widely adopted, the risk that competitors will offer solutions that will effectively commoditize our products which, in turn, will reduce the sales prices for those products; (ii) our plans are dependent upon adoption of our UC&C solution by major platform providers and any proprietary solutions of competitors, and our influence over such providers and the marketing in general with respect to the functionality of their platforms or their product offerings, their rate of deployment, and their willingness to integrate their platforms and product offerings with our solutions is limited; (iii) delays or limitations on our ability to timely introduce solutions that are cost effective, feature-rich, stable, and attractive to our customers within forecasted development budgets; (iv) our successful implementation and execution of new and different processes involving the design, development, and manufacturing of complex electronic systems composed of hardware, firmware, and software that works seamlessly and continuously in a wide variety of environments and with multiple devices; (v) failure of UC&C solutions generally, or our solutions in particular, to be adopted with the breadth and speed we anticipate; (vi) our sales model and expertise must successfully evolve to support complex integration of hardware, software, and services with UC&C infrastructure consistent with changing customer purchasing expectations; (vii) as UC&C becomes more widely adopted we anticipate that competition for market share will increase, particularly given that some competitors may have superior technical and economic resources; (viii) sales cycles for UC&C deployments are longer and becoming more complex; (ix) our inability to timely and cost-effectively adapt to changing business requirements may impact our profitability in this market and our overall margins; and (x) our failure to expand our technical support capabilities to support the complex and proprietary platforms in which our UC&C products are and will be integrated;
|
•
|
risks associated with our channel partners’ sales reporting, product inventories and product sell through since we sell a significant amount of products to channel partners who maintain their own inventory of our products;
|
•
|
failure to match production to demand given long lead times and the difficulty of forecasting unit volumes and acquiring the component parts and materials to meet demand without having excess inventory or incurring cancellation charges;
|
•
|
risks associated with forecasting sales and procurement demands, which are inherently difficult, particularly with continuing uncertainty in regional and global economic conditions as well as currency fluctuations, and there can be no assurance that expectations of incoming orders over the balance of the current quarter will materialize;
|
•
|
volatility in prices and availability of components from our suppliers, including our manufacturers located in APAC, have in the past and could in the future negatively affect our profitability and/or market share;
|
•
|
fluctuations in foreign exchange rates;
|
•
|
new or greater tariffs on our products;
|
•
|
the bankruptcy or financial weakness of distributors or key customers, or the bankruptcy of or reduction in capacity of our key suppliers;
|
•
|
additional risk factors including: interruption in the supply of sole-sourced critical components, continuity of component supply at costs consistent with our plans, and the inherent risks of our substantial foreign operations;
|
•
|
seasonality in one or more of our product categories;
|
•
|
the potential impact to our results of operations from tax rulings and interpretations;
|
•
|
risks related to our forecasts and expectations regarding liquidity, capital resources and results of operations along with our intentions concerning the repayment of our debt obligations and our ability to draw funds on our credit facility as needed;
|
•
|
potential fluctuations in our cash provided by operating activities;
|
•
|
risks associated with our anticipated range of capital expenditures for the remainder of Fiscal Year 2020;
|
•
|
the sufficiency of our cash, cash equivalents, and cash from operations to sustain future operations and discretionary cash requirements;
|
•
|
our expenses and expenditures, including research, development and engineering as well selling, general and administrative;
|
•
|
changes in tax laws that could increase our future tax rate and payments related to unrecognized tax benefits and/or reduce our deferred tax assets;
|
•
|
risks related to our forecasts and estimates with respect to tax matters, including expectations with respect to utilizing our deferred tax assets;
|
•
|
if we are unable to generate sufficient amount of income, a substantial valuation allowance to reduce the deferred tax assets may be required;
|
•
|
our ability to pay future stockholder dividends or repurchase stock;
|
•
|
our beliefs concerning interest rates and foreign currency exchange rates, our exposure to changes in each, and the benefits and risks of our hedging activities;
|
•
|
the risks of global health issues impacting supply chain, distribution, product availability, sales execution and/or other business disruption to our business;
|
•
|
risks related to adverse results in pending litigation or other regulatory proceedings; and
|
•
|
those risks and uncertainties discussed in this Quarterly Report on Form 10-Q; in Part I, "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 31, 2019, filed with the Securities and Exchange Commission (“SEC”) on May 17, 2019; and other documents we have filed with the SEC.
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||||||||||
|
|
December 31,
|
|
Increase
|
|
December 31,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2019
|
|
2018
|
|
(Decrease)
|
|
2019
|
|
2018
|
|
(Decrease)
|
||||||||||||||||||
Total net revenues
|
|
$
|
384,471
|
|
|
$
|
501,669
|
|
|
$
|
(117,198
|
)
|
|
(23.4
|
)%
|
|
$
|
1,293,947
|
|
|
$
|
1,206,047
|
|
|
$
|
87,900
|
|
|
7.3
|
%
|
Cost of revenues
|
|
240,625
|
|
|
286,532
|
|
|
(45,907
|
)
|
|
(16.0
|
)%
|
|
731,384
|
|
|
728,438
|
|
|
2,946
|
|
|
0.4
|
%
|
||||||
Gross profit
|
|
$
|
143,846
|
|
|
$
|
215,137
|
|
|
$
|
(71,291
|
)
|
|
(33.1
|
)%
|
|
$
|
562,563
|
|
|
$
|
477,609
|
|
|
$
|
84,954
|
|
|
17.8
|
%
|
Gross profit %
|
|
37.4
|
%
|
|
42.9
|
%
|
|
|
|
|
|
|
43.5
|
%
|
|
39.6
|
%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
||||||||||||||||||||||
|
|
December 31,
|
|
Increase
|
|
December 31,
|
|
Increase
|
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2019
|
|
2018
|
|
(Decrease)
|
|
2019
|
|
2018
|
|
(Decrease)
|
|
||||||||||||||||||
Research, development, and engineering
|
|
$
|
53,769
|
|
|
$
|
59,661
|
|
|
$
|
(5,892
|
)
|
|
(10
|
)%
|
|
$
|
170,708
|
|
|
$
|
140,409
|
|
|
$
|
30,299
|
|
|
22
|
%
|
|
Selling, general and administrative
|
|
144,978
|
|
|
168,053
|
|
|
(23,075
|
)
|
|
(14
|
)%
|
|
457,004
|
|
|
406,553
|
|
|
50,451
|
|
|
12
|
%
|
|
||||||
Gain, net of litigation settlements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
%
|
|
(1,162
|
)
|
|
(30
|
)
|
|
(1,132
|
)
|
|
(3,773
|
)%
|
|
||||||
Restructuring and other related charges
|
|
21,724
|
|
|
12,130
|
|
|
9,594
|
|
|
79
|
%
|
|
47,096
|
|
|
20,711
|
|
|
26,385
|
|
|
127
|
%
|
|
||||||
Total Operating Expenses
|
|
$
|
220,471
|
|
|
$
|
239,844
|
|
|
$
|
(19,373
|
)
|
|
(8
|
)%
|
|
$
|
673,646
|
|
|
$
|
567,643
|
|
|
$
|
106,003
|
|
|
19
|
%
|
|
% of net revenues
|
|
57.3
|
%
|
|
47.8
|
%
|
|
|
|
|
|
52.1
|
%
|
|
47.1
|
%
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
|
||||||||||||||||||||
|
|
December 31,
|
|
(Increase)
|
|
December 31,
|
|
(Increase)
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2019
|
|
2018
|
|
Decrease
|
|
2019
|
|
2018
|
|
Decrease
|
||||||||||||||||||
Interest expense
|
|
$
|
(22,533
|
)
|
|
$
|
(25,032
|
)
|
|
$
|
2,499
|
|
|
10.0
|
%
|
|
$
|
(70,262
|
)
|
|
$
|
(56,252
|
)
|
|
$
|
(14,010
|
)
|
|
(24.9
|
)%
|
% of net revenues
|
|
(5.9
|
)%
|
|
(5.0
|
)%
|
|
|
|
|
|
(5.4
|
)%
|
|
(4.7
|
)%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
||||||||||||||||||||
|
|
December 31,
|
|
Increase
|
|
December 31,
|
|
Increase
|
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2019
|
|
2018
|
|
(Decrease)
|
|
2019
|
|
2018
|
|
(Decrease)
|
|
||||||||||||||||||
Other non-operating income, net
|
|
$
|
967
|
|
|
$
|
125
|
|
|
$
|
842
|
|
|
673.6
|
%
|
|
$
|
675
|
|
|
$
|
3,731
|
|
|
$
|
(3,056
|
)
|
|
(81.9
|
)%
|
|
% of net revenues
|
|
0.3
|
%
|
|
—
|
%
|
|
|
|
|
|
0.1
|
%
|
|
0.3
|
%
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
||||||||||||||||||
|
|
December 31,
|
|
(Increase)
|
|
December 31,
|
|
(Increase)
|
|
||||||||||||||||||||||
(in thousands except percentages)
|
|
2019
|
|
2018
|
|
Decrease
|
|
2019
|
|
2018
|
|
Decrease
|
|
||||||||||||||||||
Loss before income taxes
|
|
$
|
(98,191
|
)
|
|
$
|
(49,614
|
)
|
|
$
|
(48,577
|
)
|
|
(97.9
|
)%
|
|
$
|
(180,670
|
)
|
|
$
|
(142,555
|
)
|
|
$
|
(38,115
|
)
|
|
(26.7
|
)%
|
|
Income tax benefit
|
|
(19,708
|
)
|
|
(7,880
|
)
|
|
(11,828
|
)
|
|
(150.1
|
)%
|
|
(31,406
|
)
|
|
(28,584
|
)
|
|
(2,822
|
)
|
|
(9.9
|
)%
|
|
||||||
Net loss
|
|
$
|
(78,483
|
)
|
|
$
|
(41,734
|
)
|
|
$
|
(36,749
|
)
|
|
(88.1
|
)%
|
|
$
|
(149,264
|
)
|
|
$
|
(113,971
|
)
|
|
$
|
(35,293
|
)
|
|
(31.0
|
)%
|
|
Effective tax rate
|
|
(20.1
|
)%
|
|
(15.9
|
)%
|
|
|
|
|
|
|
(17.4
|
)%
|
|
(20.1
|
)%
|
|
|
|
|
|
Operating Cash Flow (in millions)
|
Investing Cash Flow (in millions)
|
Financing Cash Flow (in millions)
|
|
|
|
|
December 31,
2019 |
|
March 31,
2019 |
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
156,821
|
|
|
$
|
202,509
|
|
Short-term investments
|
15,317
|
|
|
13,332
|
|
||
Accounts receivable, net
|
246,318
|
|
|
337,671
|
|
||
Inventory, net
|
215,038
|
|
|
177,146
|
|
||
Other current assets
|
54,533
|
|
|
50,488
|
|
||
Total current assets
|
688,027
|
|
|
781,146
|
|
||
Property, plant, and equipment, net
|
177,482
|
|
|
204,826
|
|
||
Goodwill
|
1,279,897
|
|
|
1,278,380
|
|
||
Purchased intangibles, net
|
688,258
|
|
|
825,675
|
|
||
Deferred tax assets
|
34,647
|
|
|
5,567
|
|
||
Other assets
|
62,556
|
|
|
20,941
|
|
||
Total assets
|
$
|
2,930,867
|
|
|
$
|
3,116,535
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Accounts payable
|
$
|
122,314
|
|
|
$
|
129,514
|
|
Accrued liabilities
|
363,394
|
|
|
398,715
|
|
||
Total current liabilities
|
485,708
|
|
|
528,229
|
|
||
Long term debt, net of issuance costs
|
1,620,354
|
|
|
1,640,801
|
|
||
Long-term income taxes payable
|
98,386
|
|
|
83,121
|
|
||
Other long-term liabilities
|
138,342
|
|
|
142,697
|
|
||
Total liabilities
|
2,342,790
|
|
|
2,394,848
|
|
||
Commitments and contingencies (Note 8)
|
|
|
|
|
|
||
Stockholders' equity:
|
|
|
|
|
|
||
Common stock
|
891
|
|
|
884
|
|
||
Additional paid-in capital
|
1,479,880
|
|
|
1,431,607
|
|
||
Accumulated other comprehensive loss
|
(5,425
|
)
|
|
(475
|
)
|
||
Retained earnings
|
(23,926
|
)
|
|
143,344
|
|
||
Total stockholders' equity before treasury stock
|
1,451,420
|
|
|
1,575,360
|
|
||
Less: Treasury stock, at cost
|
(863,343
|
)
|
|
(853,673
|
)
|
||
Total stockholders' equity
|
588,077
|
|
|
721,687
|
|
||
Total liabilities and stockholders' equity
|
$
|
2,930,867
|
|
|
$
|
3,116,535
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Net revenues
|
|
|
|
|
|
|
|
||||||||
Net product revenues
|
$
|
316,633
|
|
|
$
|
445,441
|
|
|
$
|
1,094,515
|
|
|
$
|
1,102,012
|
|
Net service revenues
|
67,838
|
|
|
56,228
|
|
|
199,432
|
|
|
104,035
|
|
||||
Total net revenues
|
384,471
|
|
|
501,669
|
|
|
1,293,947
|
|
|
1,206,047
|
|
||||
Cost of revenues
|
|
|
|
|
|
|
|
||||||||
Cost of product revenues
|
220,469
|
|
|
259,673
|
|
|
658,408
|
|
|
676,616
|
|
||||
Cost of service revenues
|
20,156
|
|
|
26,859
|
|
|
72,976
|
|
|
51,822
|
|
||||
Total cost of revenues
|
240,625
|
|
|
286,532
|
|
|
731,384
|
|
|
728,438
|
|
||||
Gross profit
|
143,846
|
|
|
215,137
|
|
|
562,563
|
|
|
477,609
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Research, development, and engineering
|
53,769
|
|
|
59,661
|
|
|
170,708
|
|
|
140,409
|
|
||||
Selling, general, and administrative
|
144,978
|
|
|
168,053
|
|
|
457,004
|
|
|
406,553
|
|
||||
Gain, net from litigation settlements
|
—
|
|
|
—
|
|
|
(1,162
|
)
|
|
(30
|
)
|
||||
Restructuring and other related charges
|
21,724
|
|
|
12,130
|
|
|
47,096
|
|
|
20,711
|
|
||||
Total operating expenses
|
220,471
|
|
|
239,844
|
|
|
673,646
|
|
|
567,643
|
|
||||
Operating loss
|
(76,625
|
)
|
|
(24,707
|
)
|
|
(111,083
|
)
|
|
(90,034
|
)
|
||||
Interest expense
|
(22,533
|
)
|
|
(25,032
|
)
|
|
(70,262
|
)
|
|
(56,252
|
)
|
||||
Other non-operating income, net
|
967
|
|
|
125
|
|
|
675
|
|
|
3,731
|
|
||||
Loss before income taxes
|
(98,191
|
)
|
|
(49,614
|
)
|
|
(180,670
|
)
|
|
(142,555
|
)
|
||||
Income tax benefit
|
(19,708
|
)
|
|
(7,880
|
)
|
|
(31,406
|
)
|
|
(28,584
|
)
|
||||
Net loss
|
$
|
(78,483
|
)
|
|
$
|
(41,734
|
)
|
|
$
|
(149,264
|
)
|
|
$
|
(113,971
|
)
|
|
|
|
|
|
|
|
|
||||||||
Loss per common share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
(1.97
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(3.78
|
)
|
|
$
|
(3.08
|
)
|
Diluted
|
$
|
(1.97
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(3.78
|
)
|
|
$
|
(3.08
|
)
|
|
|
|
|
|
|
|
|
||||||||
Shares used in computing loss per common share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
39,784
|
|
|
39,314
|
|
|
39,535
|
|
|
37,063
|
|
||||
Diluted
|
39,784
|
|
|
39,314
|
|
|
39,535
|
|
|
37,063
|
|
||||
|
|
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Net loss
|
$
|
(78,483
|
)
|
|
$
|
(41,734
|
)
|
|
$
|
(149,264
|
)
|
|
$
|
(113,971
|
)
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments
|
—
|
|
|
115
|
|
|
(219
|
)
|
|
(1,700
|
)
|
||||
Unrealized gains (losses) on cash flow hedges:
|
|
|
|
|
|
|
|
||||||||
Unrealized cash flow hedge gains (losses) arising during the period
|
(1,420
|
)
|
|
(5,622
|
)
|
|
(5,755
|
)
|
|
(853
|
)
|
||||
Net (gains) losses reclassified into income for revenue hedges
|
(225
|
)
|
|
(1,488
|
)
|
|
(3,152
|
)
|
|
(2,637
|
)
|
||||
Net (gains) losses reclassified into income for cost of revenue hedges
|
(46
|
)
|
|
6
|
|
|
(212
|
)
|
|
(73
|
)
|
||||
Net (gains) losses reclassified into income for interest rate swaps
|
1,565
|
|
|
1,029
|
|
|
3,162
|
|
|
2,006
|
|
||||
Net unrealized gains (losses) on cash flow hedges
|
(126
|
)
|
|
(6,075
|
)
|
|
(5,957
|
)
|
|
(1,557
|
)
|
||||
Unrealized gains (losses) on investments:
|
|
|
|
|
|
|
|
||||||||
Unrealized holding gains (losses) during the period
|
—
|
|
|
—
|
|
|
—
|
|
|
198
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Aggregate income tax benefit of the above items
|
81
|
|
|
1,324
|
|
|
1,228
|
|
|
1,222
|
|
||||
Other comprehensive loss
|
(45
|
)
|
|
(4,636
|
)
|
|
(4,948
|
)
|
|
(1,837
|
)
|
||||
Comprehensive loss
|
$
|
(78,528
|
)
|
|
$
|
(46,370
|
)
|
|
$
|
(154,212
|
)
|
|
$
|
(115,808
|
)
|
|
Nine Months Ended
|
||||||
|
December 31,
|
||||||
|
2019
|
|
2018
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
||||
Net loss
|
$
|
(149,264
|
)
|
|
$
|
(113,971
|
)
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
172,630
|
|
|
142,763
|
|
||
Amortization of debt issuance costs
|
4,062
|
|
|
3,188
|
|
||
Stock-based compensation
|
41,499
|
|
|
30,709
|
|
||
Deferred income taxes
|
(66,171
|
)
|
|
(39,987
|
)
|
||
Provision for excess and obsolete inventories
|
19,076
|
|
|
4,881
|
|
||
Restructuring and related charges
|
47,096
|
|
|
20,711
|
|
||
Cash payments for restructuring charges
|
(29,885
|
)
|
|
(11,222
|
)
|
||
Other operating activities
|
3,201
|
|
|
9,070
|
|
||
Changes in assets and liabilities, net of acquisition:
|
|
|
|
|
|||
Accounts receivable, net
|
34,634
|
|
|
(35,938
|
)
|
||
Inventory, net
|
(49,320
|
)
|
|
11,018
|
|
||
Current and other assets
|
24,142
|
|
|
30,456
|
|
||
Accounts payable
|
(10,690
|
)
|
|
16,519
|
|
||
Accrued liabilities
|
(46,906
|
)
|
|
72,677
|
|
||
Income taxes
|
22,251
|
|
|
(21,631
|
)
|
||
Cash provided by operating activities
|
16,355
|
|
|
119,243
|
|
||
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|||
Proceeds from sales of investments
|
177
|
|
|
125,799
|
|
||
Proceeds from maturities of investments
|
—
|
|
|
131,017
|
|
||
Purchase of investments
|
(972
|
)
|
|
(698
|
)
|
||
Cash paid for acquisition, net of cash acquired
|
—
|
|
|
(1,642,241
|
)
|
||
Capital expenditures
|
(16,984
|
)
|
|
(16,148
|
)
|
||
Proceeds from sale of property and equipment
|
2,142
|
|
|
—
|
|
||
Cash used for investing activities
|
(15,637
|
)
|
|
(1,402,271
|
)
|
||
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|||
Repurchase of common stock
|
—
|
|
|
(4,780
|
)
|
||
Employees' tax withheld and paid for restricted stock and restricted stock units
|
(9,669
|
)
|
|
(13,863
|
)
|
||
Proceeds from issuances under stock-based compensation plans
|
6,617
|
|
|
14,925
|
|
||
Proceeds from debt issuance, net
|
—
|
|
|
1,244,713
|
|
||
Payment of cash dividends
|
(17,910
|
)
|
|
(16,953
|
)
|
||
Repayments of long-term debt
|
(25,000
|
)
|
|
—
|
|
||
Cash (used for) by financing activities
|
(45,962
|
)
|
|
1,224,042
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(444
|
)
|
|
(3,519
|
)
|
||
Net decrease in cash and cash equivalents
|
(45,688
|
)
|
|
(62,505
|
)
|
||
Cash and cash equivalents at beginning of period
|
202,509
|
|
|
390,661
|
|
||
Cash and cash equivalents at end of period
|
$
|
156,821
|
|
|
$
|
328,156
|
|
SUPPLEMENTAL DISCLOSURES
|
|
|
|
||||
Cash paid for income taxes
|
$
|
9,853
|
|
|
$
|
30,902
|
|
Cash paid for interest
|
$
|
68,039
|
|
|
$
|
54,386
|
|
|
Three Months Ended December 31, 2019
|
|||||||||||||||||||||||||
|
Common Stock
|
|
Additional Paid-In
|
|
Accumulated Other Comprehensive
|
|
Retained
|
|
Treasury
|
|
Total Stockholders'
|
|||||||||||||||
|
Shares
|
|
Amount
|
|
Capital
|
|
Loss
|
|
Earnings
|
|
Stock
|
|
Equity
|
|||||||||||||
Balances at September 30, 2019
|
39,917
|
|
|
$
|
890
|
|
|
$
|
1,465,978
|
|
|
$
|
(5,351
|
)
|
|
$
|
60,545
|
|
|
$
|
(862,955
|
)
|
|
$
|
659,107
|
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(78,483
|
)
|
|
—
|
|
|
(78,483
|
)
|
||||||
Net unrealized gains (losses) on cash flow hedges, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(74
|
)
|
|
—
|
|
|
—
|
|
|
(74
|
)
|
||||||
Proceeds from issuances under stock-based compensation plans
|
28
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
||||||
Repurchase of restricted common stock
|
(3
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Cash dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,988
|
)
|
|
—
|
|
|
(5,988
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
13,902
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,902
|
|
||||||
Employees' tax withheld and paid for restricted stock and restricted stock units
|
(13
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(388
|
)
|
|
(388
|
)
|
||||||
Balances at December 31, 2019
|
39,929
|
|
|
$
|
891
|
|
|
$
|
1,479,880
|
|
|
$
|
(5,425
|
)
|
|
$
|
(23,926
|
)
|
|
$
|
(863,343
|
)
|
|
$
|
588,077
|
|
|
Three Months Ended December 31, 2018
|
|||||||||||||||||||||||||
|
Common Stock
|
|
Additional Paid-In
|
|
Accumulated Other Comprehensive
|
|
Retained
|
|
Treasury
|
|
Total Stockholders'
|
|||||||||||||||
|
Shares
|
|
Amount
|
|
Capital
|
|
Income
|
|
Earnings
|
|
Stock
|
|
Equity
|
|||||||||||||
Balances at September 30, 2018
|
39,807
|
|
|
$
|
884
|
|
|
$
|
1,404,713
|
|
|
$
|
5,668
|
|
|
$
|
218,564
|
|
|
$
|
(839,769
|
)
|
|
$
|
790,060
|
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(41,734
|
)
|
|
—
|
|
|
(41,734
|
)
|
||||||
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
113
|
|
|
—
|
|
|
—
|
|
|
113
|
|
||||||
Net unrealized gains (losses) on cash flow hedges, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,750
|
)
|
|
—
|
|
|
—
|
|
|
(4,750
|
)
|
||||||
Proceeds from issuances under stock-based compensation plans
|
17
|
|
|
—
|
|
|
52
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
52
|
|
||||||
Repurchase of restricted common stock
|
(8
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Cash dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,969
|
)
|
|
—
|
|
|
(5,969
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
11,718
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,718
|
|
||||||
Repurchase of common stock
|
(128
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,780
|
)
|
|
(4,780
|
)
|
||||||
Employees' tax withheld and paid for restricted stock and restricted stock units
|
(11
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(522
|
)
|
|
(522
|
)
|
||||||
Deferred tax adjustment
|
—
|
|
|
—
|
|
|
30
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
30
|
|
||||||
Balances at December 31, 2018
|
39,677
|
|
|
$
|
884
|
|
|
$
|
1,416,513
|
|
|
$
|
1,031
|
|
|
$
|
170,861
|
|
|
$
|
(845,071
|
)
|
|
$
|
744,218
|
|
|
Nine Months Ended December 31, 2019
|
|||||||||||||||||||||||||
|
Common Stock
|
|
Additional Paid-In
|
|
Accumulated Other Comprehensive
|
|
Retained
|
|
Treasury
|
|
Total Stockholders'
|
|||||||||||||||
|
Shares
|
|
Amount
|
|
Capital
|
|
Loss
|
|
Earnings
|
|
Stock
|
|
Equity
|
|||||||||||||
Balances at March 31, 2019
|
39,518
|
|
|
$
|
884
|
|
|
$
|
1,431,607
|
|
|
$
|
(475
|
)
|
|
$
|
143,344
|
|
|
$
|
(853,673
|
)
|
|
$
|
721,687
|
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(149,264
|
)
|
|
—
|
|
|
(149,264
|
)
|
||||||
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
(219
|
)
|
|
—
|
|
|
—
|
|
|
(219
|
)
|
||||||
Net unrealized gains (losses) on cash flow hedges, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,731
|
)
|
|
—
|
|
|
—
|
|
|
(4,731
|
)
|
||||||
Proceeds from issuances under stock-based compensation plans
|
400
|
|
|
5
|
|
|
751
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
756
|
|
||||||
Repurchase of restricted common stock
|
(32
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Cash dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17,910
|
)
|
|
—
|
|
|
(17,910
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
41,499
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
41,499
|
|
||||||
Employees' tax withheld and paid for restricted stock and restricted stock units
|
(225
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,670
|
)
|
|
(9,670
|
)
|
||||||
Proceeds from ESPP
|
268
|
|
|
2
|
|
|
6,023
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,025
|
|
||||||
Impact of new accounting standards adoption
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(89
|
)
|
|
—
|
|
|
(89
|
)
|
||||||
Other equity changes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7
|
)
|
|
—
|
|
|
(7
|
)
|
||||||
Balances at December 31, 2019
|
39,929
|
|
|
$
|
891
|
|
|
$
|
1,479,880
|
|
|
$
|
(5,425
|
)
|
|
$
|
(23,926
|
)
|
|
$
|
(863,343
|
)
|
|
$
|
588,077
|
|
|
Nine Months Ended December 31, 2018
|
|||||||||||||||||||||||||
|
Common Stock
|
|
Additional Paid-In
|
|
Accumulated Other Comprehensive
|
|
Retained
|
|
Treasury
|
|
Total Stockholders'
|
|||||||||||||||
|
Shares
|
|
Amount
|
|
Capital
|
|
Income
|
|
Earnings
|
|
Stock
|
|
Equity
|
|||||||||||||
Balances at March 31, 2018
|
33,251
|
|
|
$
|
816
|
|
|
$
|
876,645
|
|
|
$
|
2,870
|
|
|
$
|
299,066
|
|
|
$
|
(826,427
|
)
|
|
$
|
352,970
|
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(113,971
|
)
|
|
—
|
|
|
(113,971
|
)
|
||||||
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,702
|
)
|
|
—
|
|
|
—
|
|
|
(1,702
|
)
|
||||||
Net unrealized gains (losses) on cash flow hedges, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
||||||
Proceeds from issuances under stock-based compensation plans
|
412
|
|
|
3
|
|
|
11,929
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,932
|
|
||||||
Repurchase of restricted common stock
|
(70
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Issuance of common stock for acquisition
|
6,352
|
|
|
64
|
|
|
494,201
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
494,265
|
|
||||||
Cash dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,952
|
)
|
|
—
|
|
|
(16,952
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
30,708
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
30,708
|
|
||||||
Repurchase of common stock
|
(128
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,780
|
)
|
|
(4,780
|
)
|
||||||
Employees' tax withheld and paid for restricted stock and restricted stock units
|
(202
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13,864
|
)
|
|
(13,864
|
)
|
||||||
Deferred tax adjustment
|
—
|
|
|
—
|
|
|
39
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
39
|
|
||||||
Proceeds from ESPP
|
62
|
|
|
1
|
|
|
2,991
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,992
|
|
||||||
Impact of new accounting standards adoption
|
—
|
|
|
—
|
|
|
—
|
|
|
(124
|
)
|
|
2,718
|
|
|
—
|
|
|
2,594
|
|
||||||
Balances at December 31, 2018
|
39,677
|
|
|
$
|
884
|
|
|
$
|
1,416,513
|
|
|
$
|
1,031
|
|
|
$
|
170,861
|
|
|
$
|
(845,071
|
)
|
|
$
|
744,218
|
|
(in thousands, except for remaining life)
|
|
Fair Value
|
|
Weighted Remaining Life of Intangibles
|
||
Existing technology
|
|
$
|
538,600
|
|
|
4.95
|
Customer relationships
|
|
245,100
|
|
|
5.46
|
|
Trade name/Trademarks
|
|
115,600
|
|
|
9.00
|
|
Backlog
|
|
28,100
|
|
|
0.25
|
|
Total amortizable intangible assets acquired
|
|
$
|
927,400
|
|
|
5.45
|
In-process R&D
|
|
58,000
|
|
|
|
|
Total acquired intangible assets
|
|
$
|
985,400
|
|
|
|
|
|
Pro Forma (unaudited)
|
||
|
|
Nine Months Ended December 31,
|
||
(in thousands)
|
|
2018
|
||
Total net revenues
|
|
$
|
1,465,841
|
|
Operating loss
|
|
(125,395
|
)
|
|
Net loss
|
|
$
|
(152,712
|
)
|
December 31, 2019
|
|
Amortized
Cost |
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Fair
Value |
|
Cash & Cash Equivalents
|
|
Short-term investments
(due in 1 year or less)
|
||||||||||||
Cash
|
|
$
|
156,821
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
156,821
|
|
|
$
|
156,821
|
|
|
$
|
—
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Mutual Funds
|
|
14,643
|
|
|
745
|
|
|
(71
|
)
|
|
15,317
|
|
|
—
|
|
|
15,317
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total cash, cash equivalents
and investments measured at fair value |
|
$
|
171,464
|
|
|
$
|
745
|
|
|
$
|
(71
|
)
|
|
$
|
172,138
|
|
|
$
|
156,821
|
|
|
$
|
15,317
|
|
March 31, 2019
|
|
Amortized
Cost |
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Fair
Value |
|
Cash & Cash Equivalents
|
|
Short-term investments (due in 1 year or less)
|
||||||||||||
Cash
|
|
$
|
202,509
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
202,509
|
|
|
$
|
202,509
|
|
|
$
|
—
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Mutual Funds
|
|
13,420
|
|
|
197
|
|
|
(285
|
)
|
|
13,332
|
|
|
—
|
|
|
13,332
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total cash, cash equivalents
and investments measured at fair value |
|
$
|
215,929
|
|
|
$
|
197
|
|
|
$
|
(285
|
)
|
|
$
|
215,841
|
|
|
$
|
202,509
|
|
|
$
|
13,332
|
|
|
|
December 31,
|
|
March 31,
|
||||
(in thousands)
|
|
2019
|
|
2019
|
||||
Accounts receivable
|
|
$
|
345,516
|
|
|
$
|
393,415
|
|
Provisions for promotions, rebates, and other
|
|
(96,363
|
)
|
|
(50,789
|
)
|
||
Provisions for doubtful accounts and sales allowances
|
|
(2,835
|
)
|
|
(4,956
|
)
|
||
Accounts receivable, net
|
|
$
|
246,318
|
|
|
$
|
337,671
|
|
|
|
December 31,
|
|
March 31,
|
||||
(in thousands)
|
|
2019
|
|
2019
|
||||
Raw materials
|
|
$
|
112,635
|
|
|
$
|
34,054
|
|
Work in process
|
|
610
|
|
|
274
|
|
||
Finished goods
|
|
101,793
|
|
|
142,818
|
|
||
Inventory, net
|
|
$
|
215,038
|
|
|
$
|
177,146
|
|
|
|
December 31,
|
|
March 31,
|
||||
(in thousands)
|
|
2019
|
|
2019
|
||||
Short term deferred revenue
|
|
$
|
139,825
|
|
|
$
|
133,200
|
|
Employee compensation and benefits
|
|
57,314
|
|
|
68,882
|
|
||
Operating lease liabilities, current
|
|
21,074
|
|
|
—
|
|
||
Income tax payable
|
|
17,465
|
|
|
5,692
|
|
||
Provision for returns
|
|
18,336
|
|
|
24,632
|
|
||
Marketing incentives liabilities
|
|
10,059
|
|
|
25,369
|
|
||
Discounts reserve
|
|
—
|
|
|
46,894
|
|
||
Accrued interest
|
|
7,711
|
|
|
10,425
|
|
||
Warranty obligation
|
|
12,982
|
|
|
15,736
|
|
||
VAT/Sales tax payable
|
|
6,818
|
|
|
11,804
|
|
||
Derivative liabilities
|
|
8,995
|
|
|
3,275
|
|
||
Accrued other
|
|
62,815
|
|
|
52,806
|
|
||
Accrued liabilities
|
|
$
|
363,394
|
|
|
$
|
398,715
|
|
|
|
Nine Months Ended
December 31, |
||||||
(in thousands)
|
|
2019
|
|
2018
|
||||
Warranty obligation at beginning of period
|
|
$
|
17,984
|
|
|
$
|
9,604
|
|
Polycom warranty obligation(1)
|
|
—
|
|
|
9,095
|
|
||
Warranty provision related to products shipped
|
|
14,235
|
|
|
13,533
|
|
||
Deductions for warranty claims processed
|
|
(16,015
|
)
|
|
(14,930
|
)
|
||
Adjustments related to preexisting warranties
|
|
(590
|
)
|
|
(274
|
)
|
||
Warranty obligation at end of period(1)
|
|
$
|
15,614
|
|
|
$
|
17,028
|
|
|
|
Balance Sheet
|
|
December 31,
|
|
March 31,
|
||||
(in thousands)
|
|
Classification
|
|
2019
|
|
2019
|
||||
ASSETS
|
|
|
|
|
|
|
||||
Operating right-of-use assets(1)
|
|
Other assets
|
|
$
|
42,109
|
|
|
$
|
—
|
|
LIABILITIES
|
|
|
|
|
|
|
||||
Operating lease liabilities, current(2)
|
|
Accrued liabilities
|
|
$
|
21,074
|
|
|
$
|
—
|
|
Operating lease liabilities, long-term
|
|
Other liabilities
|
|
$
|
36,194
|
|
|
$
|
—
|
|
7.
|
GOODWILL AND PURCHASED INTANGIBLE ASSETS
|
As of
|
|
December 31, 2019
|
|
March 31, 2019
|
|
|
||||||||||||
(in thousands)
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Weighted Average Remaining Useful Life
|
||||||||
Amortizing Assets
|
|
|
|
|
|
|
|
|
|
|
||||||||
Existing technology
|
|
$
|
596,757
|
|
|
$
|
(177,829
|
)
|
|
$
|
566,881
|
|
|
$
|
(86,301
|
)
|
|
3.5 years
|
Customer relationships
|
|
245,437
|
|
|
(72,440
|
)
|
|
245,481
|
|
|
(36,245
|
)
|
|
4.1 years
|
||||
Trade name/Trademarks
|
|
115,600
|
|
|
(19,267
|
)
|
|
115,600
|
|
|
(9,633
|
)
|
|
7.5 years
|
||||
Non-amortizing assets
|
|
|
|
|
|
|
|
|
|
|
||||||||
In-process R&D
|
|
—
|
|
|
—
|
|
|
29,892
|
|
|
—
|
|
|
N/A
|
||||
Total intangible assets
|
|
$
|
957,794
|
|
|
$
|
(269,536
|
)
|
|
$
|
957,854
|
|
|
$
|
(132,179
|
)
|
|
4.2 years
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Goodwill
|
|
$
|
1,279,897
|
|
|
$
|
—
|
|
|
$
|
1,278,380
|
|
|
$
|
—
|
|
|
N/A
|
in thousands
|
|
Amount
|
||
2020 (remaining three months)
|
|
$
|
46,296
|
|
2021
|
|
180,343
|
|
|
2022
|
|
166,060
|
|
|
2023
|
|
162,352
|
|
|
2024
|
|
80,940
|
|
|
Thereafter
|
|
52,267
|
|
|
|
|
$
|
688,258
|
|
(in thousands)
|
|
Operating Leases(1)
|
||
2020 (remaining three months)
|
|
$
|
6,153
|
|
2021
|
|
23,233
|
|
|
2022
|
|
19,961
|
|
|
2023
|
|
7,613
|
|
|
2024
|
|
2,724
|
|
|
Thereafter
|
|
1,102
|
|
|
Total lease payments
|
|
$
|
60,786
|
|
Less: Imputed interest(2)
|
|
(3,518
|
)
|
|
Present value of lease liabilities
|
|
$
|
57,268
|
|
|
December 31, 2019
|
|
March 31, 2019
|
||||||||||||
(in thousands)
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
||||||||
5.50% Senior Notes
|
$
|
492,030
|
|
|
$
|
495,046
|
|
|
$
|
503,410
|
|
|
$
|
493,959
|
|
Term loan facility
|
$
|
1,123,876
|
|
|
$
|
1,125,308
|
|
|
$
|
1,152,044
|
|
|
$
|
1,146,842
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
(in thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Severance
|
$
|
11,708
|
|
|
$
|
7,185
|
|
|
$
|
25,480
|
|
|
$
|
15,726
|
|
Facility
|
2,147
|
|
|
1,892
|
|
|
2,147
|
|
|
1,932
|
|
||||
Other (1)
|
932
|
|
|
3,053
|
|
|
7,798
|
|
|
3,053
|
|
||||
Non-cash asset impairment
|
6,937
|
|
|
—
|
|
|
11,671
|
|
|
—
|
|
||||
Total restructuring and other related charges
|
$
|
21,724
|
|
|
$
|
12,130
|
|
|
$
|
47,096
|
|
|
$
|
20,711
|
|
|
As of March 31, 2019
|
Adoption of ASC 842 (1)
|
Accruals
|
Cash Payments
|
Adjustments
|
As of December 31, 2019
|
||||||||||||
FY 2019 Plans
|
|
|
|
|
|
|
||||||||||||
Severance
|
$
|
5,889
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(5,720
|
)
|
$
|
154
|
|
$
|
323
|
|
Facility
|
7,376
|
|
(7,376
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||
Other
|
10
|
|
—
|
|
—
|
|
—
|
|
107
|
|
117
|
|
||||||
Total FY2019 Plans
|
$
|
13,275
|
|
$
|
(7,376
|
)
|
$
|
—
|
|
$
|
(5,720
|
)
|
$
|
261
|
|
$
|
440
|
|
FY 2020 Plans
|
|
|
|
|
|
|
||||||||||||
Severance
|
$
|
—
|
|
$
|
—
|
|
$
|
26,250
|
|
$
|
(16,566
|
)
|
$
|
(924
|
)
|
$
|
8,760
|
|
Facility
|
—
|
|
—
|
|
2,147
|
|
(77
|
)
|
—
|
|
2,070
|
|
||||||
Other
|
—
|
|
—
|
|
7,450
|
|
(7,521
|
)
|
242
|
|
171
|
|
||||||
Total FY2020 Plans
|
$
|
—
|
|
$
|
—
|
|
$
|
35,847
|
|
$
|
(24,164
|
)
|
$
|
(682
|
)
|
$
|
11,001
|
|
Severance
|
$
|
5,889
|
|
$
|
—
|
|
$
|
26,250
|
|
$
|
(22,286
|
)
|
$
|
(770
|
)
|
$
|
9,083
|
|
Facility
|
7,376
|
|
(7,376
|
)
|
2,147
|
|
(77
|
)
|
—
|
|
2,070
|
|
||||||
Other
|
10
|
|
—
|
|
7,450
|
|
(7,521
|
)
|
349
|
|
288
|
|
||||||
Grand Total
|
$
|
13,275
|
|
$
|
(7,376
|
)
|
$
|
35,847
|
|
$
|
(29,884
|
)
|
$
|
(421
|
)
|
$
|
11,441
|
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
|
||||||||||||
(in thousands)
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
||||||||
Cost of revenues
|
|
$
|
1,019
|
|
|
$
|
1,067
|
|
|
$
|
2,994
|
|
|
$
|
3,103
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Research, development, and engineering
|
|
4,584
|
|
|
2,887
|
|
|
12,516
|
|
|
7,877
|
|
|
||||
Selling, general, and administrative
|
|
8,299
|
|
|
7,765
|
|
|
25,989
|
|
|
19,729
|
|
|
||||
Stock-based compensation included in operating expenses
|
|
12,883
|
|
|
10,652
|
|
|
38,505
|
|
|
27,606
|
|
|
||||
Total stock-based compensation
|
|
13,902
|
|
|
11,719
|
|
|
41,499
|
|
|
30,709
|
|
|
||||
Income tax benefit
|
|
(2,798
|
)
|
|
(1,624
|
)
|
|
(5,941
|
)
|
|
(7,605
|
)
|
|
||||
Total stock-based compensation, net of tax
|
|
$
|
11,104
|
|
|
$
|
10,095
|
|
|
$
|
35,558
|
|
|
$
|
23,104
|
|
|
|
|
Nine Months Ended
December 31, |
||||||
(in thousands, except $ per share data)
|
|
2019
|
|
2018
|
||||
Shares of common stock repurchased in the open market
|
|
—
|
|
|
127,970
|
|||
Value of common stock repurchased in the open market
|
|
$
|
—
|
|
|
$
|
4,780
|
|
Average price per share
|
|
$
|
—
|
|
|
$
|
37.35
|
|
|
|
|
|
|
||||
Value of shares withheld in satisfaction of employee tax obligations
|
|
$
|
9,669
|
|
|
$
|
13,863
|
|
(in thousands)
|
|
December 31, 2019
|
|
March 31, 2019
|
|||||
Accumulated unrealized loss on cash flow hedges (1)
|
|
$
|
(10,040
|
)
|
|
$
|
(5,310
|
)
|
|
Accumulated foreign currency translation adjustments
|
|
4,615
|
|
|
4,835
|
|
|||
Accumulated other comprehensive loss
|
|
$
|
(5,425
|
)
|
|
$
|
(475
|
)
|
(in thousands)
|
|
December 31, 2019
|
|
March 31, 2019
|
||||
Derivative Assets(1)
|
|
|
|
|
||||
Non-designated hedges
|
|
$
|
63
|
|
|
$
|
327
|
|
Cash flow hedges
|
|
537
|
|
|
2,856
|
|
||
Total derivative assets
|
|
$
|
600
|
|
|
$
|
3,183
|
|
|
|
|
|
|
||||
Derivative Liabilities(2)
|
|
|
|
|
||||
Non-designated hedges
|
|
$
|
1,187
|
|
|
$
|
39
|
|
Cash flow hedges
|
|
1,645
|
|
|
843
|
|
||
Interest rate swap
|
|
12,855
|
|
|
8,594
|
|
||
Accrued interest
|
|
584
|
|
|
7
|
|
||
Total derivative liabilities
|
|
$
|
16,271
|
|
|
$
|
9,483
|
|
(in thousands)
|
Local Currency
|
|
USD Equivalent
|
|
Position
|
|
Maturity
|
||||
EUR
|
€
|
54,600
|
|
|
$
|
61,123
|
|
|
Sell EUR
|
|
1 month
|
GBP
|
£
|
22,700
|
|
|
$
|
29,752
|
|
|
Sell GBP
|
|
1 month
|
AUD
|
A$
|
4,400
|
|
|
$
|
3,073
|
|
|
Sell AUD
|
|
1 month
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
(in thousands)
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Gain (loss) on foreign exchange contracts
|
|
$
|
(2,508
|
)
|
|
$
|
1,784
|
|
|
$
|
813
|
|
|
$
|
6,826
|
|
(in millions)
|
|
December 31, 2019
|
|
March 31, 2019
|
||||
|
|
EUR
|
|
GBP
|
|
EUR
|
|
GBP
|
Option contracts
|
|
€120.5
|
|
£40.6
|
|
€76.8
|
|
£25.8
|
Forward contracts
|
|
€33.7
|
|
£13.5
|
|
€55.4
|
|
£18.0
|
|
Local Currency
|
USD Equivalent
|
Position
|
Maturity
|
||||
|
(in thousands)
|
(in thousands)
|
|
|
||||
MX$
|
$
|
10,580
|
|
$
|
533
|
|
Buy MXN
|
Monthly over 1 month
|
|
|
Three Months Ended December 31,
|
Nine Months Ended
December 31, |
||||||||||||
(in thousands)
|
|
2019
|
|
2018
|
2019
|
|
2018
|
||||||||
Gain (loss) included in AOCI as of beginning of period
|
|
$
|
(13,311
|
)
|
|
$
|
2,825
|
|
$
|
(7,480
|
)
|
|
$
|
(1,693
|
)
|
|
|
|
|
|
|
|
|
||||||||
Amount of gain (loss) recognized in other comprehensive income (“OCI”) (effective portion)
|
|
(1,420
|
)
|
|
(5,622
|
)
|
(5,755
|
)
|
|
(853
|
)
|
||||
|
|
|
|
|
|
|
|
||||||||
Amount of (gain) loss reclassified from OCI into net revenues (effective portion)
|
|
(225
|
)
|
|
(1,488
|
)
|
(3,152
|
)
|
|
(2,637
|
)
|
||||
Amount of (gain) loss reclassified from OCI into cost of revenues (effective portion)
|
|
(46
|
)
|
|
6
|
|
(212
|
)
|
|
(73
|
)
|
||||
Amount of (gain) loss reclassified from OCI into interest expense (effective portion)
|
|
1,565
|
|
|
1,029
|
|
3,162
|
|
|
2,006
|
|
||||
Total amount of (gain) loss reclassified from AOCI to income (loss) (effective portion)
|
|
1,294
|
|
|
(453
|
)
|
(202
|
)
|
|
(704
|
)
|
||||
|
|
|
|
|
|
|
|
||||||||
Gain (loss) included in AOCI as of end of period
|
|
$
|
(13,437
|
)
|
|
$
|
(3,250
|
)
|
$
|
(13,437
|
)
|
|
$
|
(3,250
|
)
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
(in thousands, except per share data)
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Basic loss per common share:
|
|
|
|
|
|
|
|
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
|
||||||||
Net loss
|
|
$
|
(78,483
|
)
|
|
$
|
(41,734
|
)
|
|
$
|
(149,264
|
)
|
|
$
|
(113,971
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
Denominator:
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares, basic
|
|
39,784
|
|
|
39,314
|
|
|
39,535
|
|
|
37,063
|
|
||||
Dilutive effect of employee equity incentive plans
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Weighted average common shares-diluted
|
|
39,784
|
|
|
39,314
|
|
|
39,535
|
|
|
37,063
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Basic loss per common share
|
|
$
|
(1.97
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(3.78
|
)
|
|
$
|
(3.08
|
)
|
Diluted loss per common share
|
|
$
|
(1.97
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(3.78
|
)
|
|
$
|
(3.08
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
Potentially dilutive securities excluded from diluted loss per common share because their effect is anti-dilutive
|
|
1,470
|
|
|
952
|
|
|
834
|
|
|
456
|
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
(in thousands)
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Net revenues from unaffiliated customers:
|
|
|
|
|
|
|
|
|
||||||||
Enterprise Headsets
|
|
$
|
126,155
|
|
|
$
|
173,479
|
|
|
$
|
464,172
|
|
|
$
|
511,099
|
|
Consumer Headsets
|
|
41,125
|
|
|
69,665
|
|
|
128,050
|
|
|
181,385
|
|
||||
Voice*
|
|
79,494
|
|
|
116,700
|
|
|
281,794
|
|
|
238,009
|
|
||||
Video*
|
|
69,859
|
|
|
85,597
|
|
|
220,499
|
|
|
171,519
|
|
||||
Services*
|
|
67,838
|
|
|
56,228
|
|
|
199,432
|
|
|
104,035
|
|
||||
Total net revenues
|
|
$
|
384,471
|
|
|
$
|
501,669
|
|
|
$
|
1,293,947
|
|
|
$
|
1,206,047
|
|
|
|
Three Months Ended December 31,
|
|
Nine Months Ended
December 31, |
||||||||||||
(in thousands)
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Net revenues from unaffiliated customers:
|
|
|
|
|
|
|
|
|
||||||||
U.S.
|
|
$
|
175,856
|
|
|
$
|
223,111
|
|
|
$
|
613,810
|
|
|
$
|
570,726
|
|
|
|
|
|
|
|
|
|
|
||||||||
Europe and Africa
|
|
105,931
|
|
|
146,388
|
|
|
351,883
|
|
|
338,935
|
|
||||
Asia Pacific
|
|
73,630
|
|
|
90,162
|
|
|
235,931
|
|
|
204,504
|
|
||||
Americas, excluding U.S.
|
|
29,054
|
|
|
42,008
|
|
|
92,323
|
|
|
91,882
|
|
||||
Total international net revenues
|
|
208,615
|
|
|
278,558
|
|
|
680,137
|
|
|
635,321
|
|
||||
Total net revenues
|
|
$
|
384,471
|
|
|
$
|
501,669
|
|
|
$
|
1,293,947
|
|
|
$
|
1,206,047
|
|
|
|
December 31, 2019
|
||||||||||
(in millions)
|
|
Current
|
|
Noncurrent
|
|
Total
|
||||||
Performance obligations
|
|
$
|
145.9
|
|
|
$
|
62.8
|
|
|
$
|
208.7
|
|
Currency - forward contracts
|
Position
|
|
USD Value of Net Foreign Exchange Contracts
|
|
Foreign Exchange Gain From 10% Appreciation of USD
|
|
Foreign Exchange Loss From 10% Depreciation of USD
|
||||||
EUR
|
Sell EUR
|
|
$
|
61.1
|
|
|
$
|
6.1
|
|
|
$
|
(6.1
|
)
|
GBP
|
Sell GBP
|
|
$
|
29.8
|
|
|
$
|
3.0
|
|
|
$
|
(3.0
|
)
|
AUD
|
Sell AUD
|
|
$
|
3.1
|
|
|
$
|
0.3
|
|
|
$
|
(0.3
|
)
|
Currency - option contracts
|
|
USD Value of Net Foreign Exchange Contracts
|
|
Foreign Exchange Gain From 10% Appreciation of USD
|
|
Foreign Exchange Loss From 10% Depreciation of USD
|
||||||
Call options
|
|
$
|
197.2
|
|
|
$
|
1.0
|
|
|
$
|
(6.4
|
)
|
Put options
|
|
$
|
182.6
|
|
|
$
|
9.5
|
|
|
$
|
(4.1
|
)
|
Forwards
|
|
$
|
55.2
|
|
|
$
|
5.5
|
|
|
$
|
(5.5
|
)
|
Currency - cross-currency swap contracts
|
USD Value of Cross-Currency Swap Contracts
|
Foreign Exchange (Loss) From 10% Appreciation of USD
|
Foreign Exchange Gain From 10% Depreciation of USD
|
||||||
Position: Buy MXN
|
$
|
0.5
|
|
$
|
(0.1
|
)
|
$
|
0.1
|
|
(a)
|
Evaluation of disclosure controls and procedures
|
(b)
|
Changes in internal control over financial reporting
|
|
Total Number of Shares Purchased 1
|
|
Average Price Paid per Share 2
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs 3
|
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs 3
|
|||
September 29, 2019 to October 26, 2019
|
1,134
|
|
|
N/A
|
|
—
|
|
|
1,369,014
|
|
October 27, 2019 to November 23, 2019
|
3,504
|
|
|
N/A
|
|
—
|
|
|
1,369,014
|
|
November 24, 2019 to December 28, 2019
|
8,206
|
|
|
N/A
|
|
—
|
|
|
1,369,014
|
|
1
|
|
Represents shares of our common stock that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock issued pursuant to equity awards under our 2003 Stock Plan.
|
|
|
|
2
|
|
"Average Price Paid per Share" reflects open market repurchases of common stock only.
|
|
|
|
3
|
|
On November 28, 2018, our Board of Directors approved a 1 million share repurchase program expanding our capacity to repurchase shares under a previously approved share repurchase program to approximately 1.7 million shares. Although we may repurchase shares from time to time in open market transactions or through privately negotiated transactions, we did not repurchase any shares of our common stock under the repurchase program during the third quarter of fiscal year 2020. There is no expiration date associated with the repurchase activity under the existing repurchase program.
|
Exhibit Number
|
|
|
|
Incorporation by Reference
|
|
Filed Herewith
|
||||||
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document - the XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
Inline XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
Inline XBRL Taxonomy Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104
|
|
Cover Page Interactive Data File, (formatted as Inline XBRL and contained in Exhibit 101)
|
|
|
|
|
|
|
|
|
|
X
|
|
|
PLANTRONICS, INC.
|
|
|
|
|
|
Date:
|
February 5, 2020
|
By:
|
/s/ Charles D. Boynton
|
|
|
Name:
|
Charles D. Boynton
|
|
|
Title:
|
Executive Vice President and Chief Financial Officer
|
11.
|
Waiver of Rights and Claims Under the Age Discrimination in Employment Act of 1967:
|
|
third installment of 25% of the shares granted will vest on the last calendar day of the month following the 24th month of the Award Date. Any shares that would otherwise vest and be released from escrow or settled on December 31st of any year shall instead vest on January 2nd of the succeeding year. All vesting is subject to your continued employment on each applicable vesting date.
|
General Benefits
|
You will be eligible to participate in Company benefit programs as available or that become available to other similarly situated employees of the Company, subject to the generally applicable terms and conditions of each program. The continuation or termination of each program will be at the discretion of the Company. Life, Medical, Dental and Disability coverage will begin on your start date.
|
Change of Control
|
As of your start date, you will be provided with change of control severance protection under the same form of agreement provided to our other senior officers (other than the CEO and CFO).
|
Severance Agreement
|
As of your start date, you will be provided with severance protection under the same form of agreement provided to our other senior officers (other than the CEO and CFO).
|
Executive Physical Program
|
You will be automatically enrolled in our Executive Health Exam Program. This program is aimed to give you guidance and direction on further health items to follow up on. To qualify you must schedule the appointment through the pre-identified network of doctors.
|
401(k)
|
You are eligible to join the Plantronics, Inc. 401(k). Plantronics will match 100% of every $1.00 you contribute for the first 3% of your eligible compensation and 50% of every $1.00 you contribute for the next 3% of your eligible compensation for a maximum of up to 4.5% of your eligible compensation each pay period. The matching contribution is 100% vested immediately. If after 30 days from your date of hire you have not actively selected a contribution amount to set aside each pay period, Plantronics will automatically enroll you at a discretionary employee contribution of 3% of your eligible earnings on a bi-weekly basis to the 401(k).
|
Non-Qualified Deferred Compensation Plan
|
You will be eligible to participate in a non-qualified deferred compensation plan, subject to the terms and conditions of the Plan Document. An eligible participant may elect to defer prospective compensation not yet earned by submitting a Compensation Deferral Agreement during the enrollment periods. For more information regarding the Plantronics, Inc. Deferred Compensation Plan, please see the Prospectus.
|
ESPP
|
You will be eligible to participate in the Company’s Employee Stock Purchase Plan, subject to the terms of the Plan.
|
4.
|
Certain capitalized terms used in the Agreement are defined in Section 6 below. AGREEMENT
|
4.
|
Severance Benefits.
|
(b)
|
Timing of Payments.
|
(f)
|
Section 409A.
|
(a)
|
delivered in full, or
|
(b)
|
delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code,
|
(a)
|
Cause. “Cause” will mean Executive’s termination only upon:
|
7.
|
Successors.
|
8.
|
Arbitration.
|
9.
|
Notice.
|
10.
|
Miscellaneous Provisions.
|
By:
|
/s/ Joseph B. Burton
|
4.
|
Certain capitalized terms used in the COC Agreement are defined in Section 6 below.
|
4.
|
Change of Control Benefits.
|
(b)
|
Timing of Payments.
|
(e)
|
Section 409A.
|
(a)
|
delivered in full, or
|
(b)
|
delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code,
|
(a)
|
Cause. “Cause” will mean Executive’s termination only upon:
|
7.
|
Successors.
|
8.
|
Arbitration.
|
9.
|
Notice.
|
10.
|
Miscellaneous Provisions.
|
By:
|
/s/ Joseph B. Burton
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
February 5, 2020
|
|
|
/s/ Joe Burton
|
|
Joe Burton
|
|
President, Chief Executive Officer and Director
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
February 5, 2020
|
|
|
/s/ Charles D. Boynton
|
|
Charles D. Boynton
|
|
Executive Vice President and Chief Financial Officer
|
|
By:
|
/s/ Joe Burton
|
|
Name:
|
Joe Burton
|
|
Title:
|
President, Chief Executive Officer and Director
|
|
Date:
|
February 5, 2020
|
|
By:
|
/s/ Charles D. Boynton
|
|
Name:
|
Charles D. Boynton
|
|
Title:
|
Executive Vice President and Chief Financial Officer
|
|
Date:
|
February 5, 2020
|